Annual Debt To Equity
3.56
+2.71+318.82%
December 31, 2023
Summary
- As of February 7, 2025, EPRX annual debt to equity ratio is 3.56, with the most recent change of +2.71 (+318.82%) on December 31, 2023.
- During the last 3 years, EPRX annual debt to equity has risen by +4.16 (+693.33%).
- EPRX annual debt to equity is now at all-time high.
Performance
EPRX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
0.01
-0.30-96.77%
September 1, 2024
Summary
- As of February 7, 2025, EPRX quarterly debt to equity ratio is 0.01, with the most recent change of -0.30 (-96.77%) on September 1, 2024.
- Over the past year, EPRX quarterly debt to equity has dropped by -0.30 (-96.77%).
- EPRX quarterly debt to equity is now -99.79% below its all-time high of 4.72, reached on December 31, 2023.
Performance
EPRX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
EPRX Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +318.8% | -96.8% |
| 3 y3 years | +693.3% | -97.9% |
| 5 y5 years | +1147.1% | - |
EPRX Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +657.5% | -99.8% | at low |
| 5 y | 5-year | at high | +631.3% | -99.8% | +101.5% |
| alltime | all time | at high | +631.3% | -99.8% | +101.5% |
Eupraxia Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 0.01(-96.8%) |
| Jun 2024 | - | 0.31(-36.7%) |
| Mar 2024 | - | 0.49(-89.6%) |
| Dec 2023 | 3.56(+318.8%) | 4.72(+424.4%) |
| Sep 2023 | - | 0.90(-40.0%) |
| Jun 2023 | - | 1.50(+30.4%) |
| Dec 2022 | 0.85 | - |
| Dec 2022 | - | 1.15(+125.5%) |
| Sep 2022 | - | 0.51(+24.4%) |
| Jun 2022 | - | 0.41(-28.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 0.57(+21.3%) |
| Dec 2021 | 0.47(-178.3%) | 0.47(+17.5%) |
| Sep 2021 | - | 0.40(+29.0%) |
| Jun 2021 | - | 0.31(+24.0%) |
| Mar 2021 | - | 0.25(-141.7%) |
| Dec 2020 | -0.60(-10.4%) | -0.60(+1.7%) |
| Sep 2020 | - | -0.59(-11.9%) |
| Dec 2019 | -0.67(+97.1%) | -0.67 |
| Dec 2018 | -0.34(<-9900.0%) | - |
| Dec 2017 | 0.00 | - |
FAQ
- What is Eupraxia Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual debt to equity year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly debt to equity year-on-year change?
What is Eupraxia Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of EPRX is 3.56
What is the all time high annual debt to equity for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual debt to equity ratio is 3.56
What is Eupraxia Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, EPRX annual debt to equity ratio has changed by +2.71 (+318.82%)
What is Eupraxia Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of EPRX is 0.01
What is the all time high quarterly debt to equity for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly debt to equity ratio is 4.72
What is Eupraxia Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, EPRX quarterly debt to equity ratio has changed by -0.30 (-96.77%)